Safety and efficacy of sodium-glucose cotransporter-2 inhibitors in adults with type 2 diabetes fasting during Ramadan: A meta-analysis

Figure 1 Flowchart on study retrieval and inclusion in the meta-analysis. SGLT2i: Sodium-glucose cotransporter-2 inhibitors.

Figure 2 Forest plot demonstrating the mean differences in glycated hemoglobin and fasting plasma glucose in the sodium-glucose cotransporter-2 inhibitors group vs the non-sodium-glucose cotransporter-2 inhibitors group. A: Glycated hemoglobin; B: Fasting plasma glucose. SGLT2i: Sodium-glucose cotransporter-2 inhibitors.

Figure 3 Forest plot demonstrating the mean differences in body weight, body mass index, and waist circumference in the sodium-glucose cotransporter-2 inhibitors group vs the non-sodium-glucose cotransporter-2 inhibitors group. A: Body weight; B: Body mass index; C: Waist circumference. SGLT2i: Sodium-glucose cotransporter-2 inhibitors.

Figure 4 Forest plot demonstrating the mean differences in systolic blood pressure and diastolic blood pressure in the sodium-glucose cotransporter-2 inhibitors group vs the non-sodium-glucose cotransporter-2 inhibitors group. A: Systolic blood pressure; B: Diastolic blood pressure. SGLT2i: Sodium-glucose cotransporter-2 inhibitors.